Amarin | GJELD



Debt Endring Dato
AbbVie USD 67.14B 3.94B 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Amarin USD 0 0 2024-09
AstraZeneca USD 30.3B 1.27B 2024-12
DBV Technologies USD 0 0 2024-09
GlaxoSmithKline GBP 16.99B 927M 2024-12
Halozyme Therapeutics USD 1.51B 1.64M 2024-12
Ionis Pharmaceuticals USD 1.25B 32.8M 2024-12
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 31.26B 828M 2024-12



Amarin GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.